Search by Drug Name or NDC

NDC 73320-0003-01 BACLOFEN 20 mg/1 Details

BACLOFEN 20 mg/1

BACLOFEN is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Kartha Pharmaceuticals, Inc.. The primary component is BACLOFEN.

MedlinePlus Drug Summary

Baclofen is used to treat pain and certain types of spasticity (muscle stiffness and tightness) from multiple sclerosis, spinal cord injuries, or other spinal cord diseases. Baclofen is in a class of medications called skeletal muscle relaxants. Baclofen acts on the spinal cord nerves and decreases the number and severity of muscle spasms caused by multiple sclerosis or spinal cord conditions. It also relieves pain and improves muscle movement.

Related Packages: 73320-0003-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Baclofen

Product Information

NDC	73320-0003
Product ID	73320-003_21dc3dc4-c5a7-4075-95e9-64668dc205d8
Associated GPIs	75100010000310
GCN Sequence Number	004680
GCN Sequence Number Description	baclofen TABLET 20 MG ORAL
HIC3	H6H
HIC3 Description	SKELETAL MUSCLE RELAXANTS
GCN	18011
HICL Sequence Number	001949
HICL Sequence Number Description	BACLOFEN
Brand/Generic	Generic
Proprietary Name	BACLOFEN
Proprietary Name Suffix	n/a
Non-Proprietary Name	BACLOFEN
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	20
Active Ingredient Units	mg/1
Substance Name	BACLOFEN
Labeler Name	Kartha Pharmaceuticals, Inc.
Pharmaceutical Class	GABA A Agonists [MoA], GABA B Agonists [MoA], gamma-Aminobutyric Acid-ergic Agonist [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA214374
Listing Certified Through	2024-12-31

Package

NDC 73320-0003-01 (73320000301)

Pricing Information	N/A
NDC Package Code	73320-003-01
Billing NDC	73320000301
Package	30 TABLET in 1 BOTTLE (73320-003-01)
Marketing Start Date	2021-07-01
NDC Exclude Flag	N